Form 4: UAMY Director Joseph Carrabba Receives Equity Awards
Insider Transaction Disclosure
United States Antimony Corp. Director Joseph A. Carrabba was granted restricted stock units and stock options under the company's 2023 Equity Incentive Plan.
Summary
- Joseph A. Carrabba, a Director of United States Antimony Corp. (UAMY), received equity awards on January 15, 2026.
- The awards include a time-based vesting restricted stock unit (RSU) award of 19,903 shares of Common Stock.
- One-third, or 6,635 shares, of the RSU award vested on January 15, 2026, with additional one-third portions vesting on January 15, 2027, and January 18, 2028.
- Carrabba's beneficial ownership of Common Stock following this transaction is 112,702 shares.
- A time-based vesting stock option award for 12,259 shares of Common Stock was also granted, with an exercise price of $8.29 per share.
- The stock option award will vest as to one-third (4,087 shares) on January 15, 2027, and additional one-third portions on January 18, 2028, and January 16, 2029.
- All vesting is subject to Carrabba's continued service through each vesting date.
Sentiment
Score: 6
Explanation: The filing reports a standard equity compensation grant to a director, which is generally viewed as a positive for aligning interests, but does not contain performance-related news.
Positives
- The grant of restricted stock units and stock options aligns the director's interests with those of shareholders, incentivizing long-term performance.
- The equity awards are part of the company's Amended & Restated 2023 Equity Incentive Plan, indicating a structured approach to executive and director compensation.
Future Outlook
The equity awards are structured with time-based vesting schedules extending through January 2029, contingent on the director's continued service, indicating a long-term incentive strategy.
Industry Context
This filing is a routine disclosure of director compensation through equity grants, a common practice across various industries to align management and director incentives with shareholder value.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Incentive Plan Utilization | The equity awards were granted under the Issuer's Amended & Restated 2023 Equity Incentive Plan, demonstrating the ongoing implementation of the company's approved compensation framework. | 01/15/2026 | Reinforces the company's commitment to performance-based compensation and aligns director incentives with long-term shareholder value. |
Stakeholder Impact
- Shareholders: The equity grants are intended to align the director's long-term interests with shareholder value, potentially leading to improved governance and performance. However, they also represent potential future dilution upon vesting and exercise.
Next Steps
- Continued service of Joseph A. Carrabba through future vesting dates (January 15, 2027; January 18, 2028; January 16, 2029) for full vesting of equity awards.
Key Dates
| Date | Description |
|---|---|
| 01/15/2026 | Date of grant for RSU and stock option awards; vesting date for 6,635 RSU shares. |
| 01/23/2026 | Signature date of the reporting person, Joseph Carrabba. |
| 01/15/2027 | Vesting date for an additional one-third of the RSU award and one-third (4,087 shares) of the stock option award. |
| 01/18/2028 | Vesting date for an additional one-third of the RSU award and one-third of the stock option award. |
| 01/16/2029 | Vesting date for the final one-third of the stock option award. |
Keywords
UAMY, United States Antimony Corp, Form 4, Insider Transaction, Equity Grant, Restricted Stock Unit, Stock Option, Director Compensation, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.